Apoptotic Characteristics of Cell Death and the Neuroprotective Effect of Homocarnosine on Pheochromocytoma PC12 Cells Exposed to Ischemia

Journal of Neuroscience Research

Volumn 75, Issue 4, 2004, Pages 499-507

  Tabakman, Rinat ^a   Jiang, Hao ^b   Levine, Robert A ^b   Kohen, Ron ^a   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Apoptosis; Homocarnosine; Ischemia; Neuroprotection; PC12

Indexed keywords

CASPASE 3; CYCLIN D1; CYTOCHROME C; DNA FRAGMENT; GLUCOSE; HOMOCARNOSINE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXYGEN; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; ISCHEMIA; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; REOXYGENATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CARNOSINE; CELL DEATH; CELL HYPOXIA; NEUROPROTECTIVE AGENTS; PC12 CELLS; PHOSPHORYLATION; RATS;

EID: 0742270427     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20008     Document Type: Article

References (56)

1. Abu Raya S, Trembovler V, Shohami E, Lazarovici P. 1993. A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC12 cultures. J Neurosci Methods 50:197-203.
2. Alabovsky VV, Boldyrev AA, Vinokurov AA, Shchavratsky VK. 1997. Effect of histidine-containing dipeptides on isolated heart under ischemia/ reperfusion. Biochemistry [Moscow] 62:77-87.
3. Anastasiadis PZ, Jiang H, Bezin L, Kuhn DM, Levine RA. 2001. Tetrahydrobiopterin enhances apoptotic PC12 cell death following withdrawal of trophic support. J Biol Chem 276:9050-9058.
4. Banasiak KJ, Xia Y, Haddad GG. 2000. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 62:215-249.
5. Bloch-Shilderman E, Jiang H, Abu-Raya S, Linial M, Lazarovici P. 2001. Involvment of extracellular signal-regulated kinase (ERK) in pardaxin-induced dopamine release from PC12 cell. J Pharmacol Exp Ther 296:701-711.
6. Bloch-Shilderman E, Jiang H, Lazarovici P. 2002. Pardaxin, an ionophore neurotoxin, induces PC12 cell death: activation of stress kinases and production of reactive oxygen species. J Nat Toxins 11:71-85.
7. Boldyrev AA, Stvolinsky SL, Tyulina OV, Koshelev VB, Hori N, Carpenter DO. 1997. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell Mol Neurobiol 17:259-271.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Brunelle JK, Chandel NS. 2002. Oxygen deprivation induced cell death: An update. Apoptosis 7:475-482.
10. Carroll JM, Toral-Barza L, Gibson G. 1992. Cytosolic free calcium and gene expression during chemical hypoxia. J Neurochem 59:1836-1843.
11. Chalmers-Redman RME, Fraser AD, Ju WYH, Wadia J, Tatton NA, Tatton WG. 1997. Mechanisms of nerve cell death: apoptosis or necrosis after cerbral ischemia. In: Green AR, Cross AJ, editors. Neuroprotective agents and cerebral ischemia. San Diego: Academic Press. p 1-25.
12. Choi SY, Kwon HY, Kwon OB, Kang JH. 1999. Hydrogen peroxide-mediated Cu,Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine and anserine. Biochim Biophys Acta 1472:651-657.
13. 2 injury. J Neurochem 82:19-29.
14. Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE. 1999a. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 274:33709-33713.
15. Conrad PW, Rust RT, Han J, Millhorn DE, Beitner-Johnson D. 1999b. Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274:23570-23576.
16. 2+/CaM in the activation of MAPK and p38 gamma. Adv Exp Med Biol 475:293-302.
17. Cowan KJ, Storey KB. 2003. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206:1107-1115.
18. Ferrari G, Batistatou A, Greene LA. 1993. Gangliosides rescue neuronal cells from death after trophic factor deprivation. J Neurosci 13:1879-1887.
19. Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gomez C, Ambrosio S. 2001. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. J Neural Transm 108:1383-1396.
20. Fujita K, Lazarovici P, Guroff G. 1989. Regulation of the differentiation of PC12 pheochromocytoma cells. Regulation of differentiation in eukaryotic cells. Environ Health Perspect 80:127-142.
21. Gabai VL, Meriin AB, Yaglom JA, Wei JY, Mosser DD, Sherman MY. 2000. Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stress-induced inhibition of JNK dephosphorylation. J Biol Chem 275:38088-38094.
22. Glicksman MA, Chiu AY, Dionne CA, Harty M, Kaneko M, Murakata C, Oppenheim RW, Prevette D, Sengelaub DR, VaughtJL, Neff NT. 1998. CEP-1347/ KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo. J Neurobiol 35:361-370.
23. Goldberg MP, Strasser U, Dugan LL. 1997. Techniques for assesing neuroprotective drugs in vitro. In: Green AR, Cross AJ, editors. Neuroprotective agents and cerebral ischaemia. San Diego: Academic Press. p 69-93.
24. Guegan C, Sola B. 2000. Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice. Brain Res 856:93-100.
25. Hatakeyama D, Kozawa O, Otsuka T, Shibata T, Uematsu T. 2002. Zinc suppresses IL-6 synthesis by prostaglandin F2alpha in osteoblasts: inhibition of phospholipase C and phospholipase D. J Cell Biochem 85:621-628.
26. Hou ST, MacManus JP. 2002. Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol 221:93-148.
27. Hreniuk D, Garay M, Gaarde W, Monia BP, McKay RA, Cioffi CL. 2001. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 59:867-874.
28. Irving EA, Bamford M. 2002. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647.
29. Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, Xu Q, Yu AC. 2002. Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun 294:726-733.
30. Khokhlatchev A, Xu S, English J, Wu P, Schaefer E, Cobb MH. 1997. Reconstitution of mitogen-activated protein kinase phosphorylation cascades in bacteria. Efficient synthesis of active protein kinases. J Biol Chem 272:11057-11062.
31. Kohen R, Yamamoto Y, Cundy KC, Ames BN. 1988. Antioxidant activity of carnosine, homocarnosine and anserine present in muscle and brain. Proc Natl Acad Sci USA 85:3175-3179.
32. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
33. Lambeng N, Willaime-Morawek S, Mariani J, Ruberg M, Brugg B. 2003. Activation of mitogen-activated protein kinase pathways during the death of PC12 cells is dependent on the state of differentiation. Brain Res Mol Brain Res 111:52-60.
34. Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA, Moskowitz MA. 2002. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA 99:15188-15193.
35. Levites Y, Amit T, Mandel S, Youdim MB. 2003. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 17:952-954.
36. Lim ML, Lum MG, Hansen TM, Roucou X, Nagley P. 2002. On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci 9:488-506.
37. Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight E Jr, Murphy CA, Bartlett BA, Finn JP, Angeles T, Matsuda Y, Neff NT, Dionne CA. 1998. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci 18:104-111.
38. Maroney AC, Finn JP, Bozyczko-Coyne D, O'Kane TM, Neff NT, Tolkovsky AM, Park DS, Yan CY, Troy CM, Greene LA. 1999. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J Neurochem 73:1901-1912.
39. Maroto R, Perez-Polo JR. 1997. BCL-2-related protein expression in apoptosis: oxidative stress versus serum deprivation in PC12 cells. J Neurochem 69:514-523.
40. Mattson MP, Duan W, Pedersen WA, Culmsee C. 2001. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6:69-81.
41. Moley KH, Mueckler MM. 2000. Glucose transport and apoptosis. Apoptosis 5:99-105.
42. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A. 2001. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA 98:11569-11574.
43. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. 1994. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 269:26546-26551.
44. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN. 1998. Toxic effects of beta-amyloid (25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 242:105-108.
45. +-induced apoptosis. EurJ Neurosci 17:1563-1570.
46. Rukenstein A, Rydel RE, Greene LA. 1991. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci 11:2552-2563.
47. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA. 1998. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17:3401-3415.
48. Schneider S, Chen W, Hou J, Steenbergen C, Murphy E. 2001. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning. Am J Physiol Heart Circ Physiol 280:499-508.
49. Seta KA, Spicer Z, Yuan Y, Lu G, Milhorn DE. 2002. Responding to hypoxia: lessons from a model cell line. Science's STKE [www.stke.org/ cgi/content/full/sigtrans;2002/146/re11].
50. Siesjo BK. 1992. Pathophysiology and treatment of focal cerebral ischemia. Part II: mechanisms of damage and treatment. J Neurosurg 77:337-354.
51. Stvolinsky SL, Dobrota D. 2000. Anti-ischemic activity of carnosine. Biochemistry [Moscow] 2000 65:849-855.
52. Subramaniam S, Strelau J, Unsicker K. 2003. Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. J Biol Chem 278:8904-8912.
53. Tabakman R, Lazarovici P, Kohen R. 2002. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 68:463-469.
54. Wiesner DA, Dawson G. 1996. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem 66:1418-1425.
55. Wilson JX, Gelb AW. 2002. Free radicals, antioxidants, and neurologic injury: possible relationship to cerebral protection by anesthetics. J Neurosurg Anesthesiol 14:66-79.
56. Zhou J, Fu Y, Tang XC. 2001. Huperzine A protects rat pheochromocytoma cells against oxygen-glucose deprivation. Neuroreport 12:2073-2077.